Vital Pulp Therapy Clinical Trial
Official title:
Effect of Topical Dexamethasone on Histologic Response of Human Dental Pulp
Abstract Aim The aim of this randomized clinical trial was to histologically investigate
possible effects of dexamethasone application on pulp tissue healing during one step mineral
trioxide aggregate (MTA)-direct pulp capping (DPC) and miniature pulpotomy (MP) in healthy
human premolar teeth.
Methodology Forty intact premolar teeth of 10 orthodontic patients, scheduled for
extraction, were randomized for DPC (n=20) or MP (n=20). A high speed bur under copious
water coolant was used for mechanical exposing of buccal pulp horn site. Prior to sealing
with white ProRoot MTA, 10 out of twenty pulpal wounds of each group were randomly received
dexamethasone. Cavities were restored with glass ionomer. Teeth vitality was evaluated in 7,
21, 42, and 60 day follow-ups. Signs and/or symptoms of irreversible pulpitis or pulp
necrosis were considered as failure. After 60 days, the teeth were extracted and submitted
for histological examination. Kruskal-Wallis and Fisher exact tests were used for
statistical analysis of the data (P=0.05).
HTTP://www.accessdata.fda.gov/scripts/cred/drugsatfda
Clinical procedures All clinical procedures took place at private office of first author (J.G.). Using simple randomization procedures (computerized random numbers), forty intact premolars were randomly assigned to 1 of 4 treatment groups (n=10): I) DPC, II) MP, III) DPC+dexamethasone, and IV) MP+dexamethasone. After administration of local anesthesia (3% mepivacaine plain; Septodont, cedax, France) dental rubber dam was applied and tooth surface disinfected with 2% chlorhexidine gluconate. Occlusal cavity was prepared using high speed diamond fissure bur and buccal pulp horn was mechanically exposed (approximately 1.2 mm in diameter) using a sterile high speed carbide round bur. In MP, depth of penetration to the pulp was 0.5 mm. All of the cavity preparation procedures were intermittently performed under copious water coolant and light hand pressure. Using a sterile 5.25% NaOCl-soaked cotton pellet, bleeding from the exposure site was controlled and 2ml of sterile saline rinsed off NaOCl residues. For blinding the practitioner to the materials, dexamethasone (Dr.abidi, Tehran, Iran) and placebo were held in identical light proof syringes and numbered for each tooth according to the randomization schedule. Each tooth was assigned an order number and its pulpal wound received the solution in the corresponding prepacked syringe prior to sealing off the exposure site with white ProRoot MTA (Dentsply, Tulsa, OK); MTA was mixed according to the manufacturer's directions and a wet cotton pellet was placed over the material for 10 minutes. Eventually, the coronal cavity was restored with light cure resin modified glass ionomer (Fuji II LC; GC Corporation, Tokyo, Japan) and cured for 40 seconds using a curing light. All clinical procedures were performed by the same practitioner (J.G.). All patients took 400 mg of ibuprofen (as a single dose) for postoperative pain control. Pulp and periapical status were clinically (7, 21, 42, and 60 days) and radiographically evaluated (42, and 60 days) during the study. Clinical and radiographic signs and/or symptoms of irreversible pulpitis or pulp necrosis were considered as treatment failure. On the 60th day teeth were extracted atraumatically and prepared for submission to the oral pathology department for processing. ;
Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06348914 -
Knowledge of Vital Pulp Therapy in Permanent Teeth Among a Group of Dental Students in Egypt
|
||
Not yet recruiting |
NCT05498337 -
Vital Pulp Therapy With Different Materials for Young Permanent Teeth
|
N/A | |
Completed |
NCT05167123 -
Pulp Capping in Primary Molars Using TheraCal (LC)
|
Phase 4 | |
Recruiting |
NCT06372561 -
Comparative Evaluation of Melatonin Versus MTA on Vital Pulp Therapy in Young Permanent First Molars: An in Vivo Study
|
N/A | |
Completed |
NCT05464797 -
Diagnostic Biomarkers to Correlate Molecular Changes and Inflammatory Cascade in the Dental Pulp.
|
N/A | |
Not yet recruiting |
NCT06111703 -
Knowledge, Attitude and Practice in Utilization of Vital Pulp Therapy in Permanent Teeth by Pediatric Dentists in Egypt
|
||
Completed |
NCT05970536 -
Vital Pulp Therapy of Mature Permanent Teeth With Irreversible Pulpitis Using Bioceramic Material
|
N/A | |
Not yet recruiting |
NCT06232941 -
Comparative Evaluation of Three Pulpotomy Agents for Permanent Mature Molars With Irreversible Pulpitis
|
N/A |